Broader NGS Use in Oncology Hinges on Payers, Access, and Education
August 16th 2019
Using up-front, broadpanel genomic tests that include hundreds of genes can save money and, in some cases, improve outcomes compared with other diagnostic approaches, especially in lung cancer but also increasingly in breast, colorectal, skin, and other cancers.